Marinus Pharmaceuticals
Latest round
- Series C
Last raised
- Jan 2013
Total raised
- $71M
Investors
- 5
About Marinus Pharmaceuticals
Based in Pennsylvania, US, and founded in 2003, Marinus Pharmaceuticals, Inc. operates as a pharmaceutical manufacturing company that develops treatments for neurological and psychiatric disorders like status epilepticus, tuberous sclerosis complex, and CDKL5 deficiency disorder. In March 2022, Marinus Pharmaceuticals, Inc.D. is the Chief Executive Officer (CEO) of the company. Marinus Pharmaceuticals, Inc. focused on the development of new treatments for epilepsy and neuropsychiatric disorders and improves the treatment methodology for patients by developing the treatment of Status Epilepticus (SE), CDKL5 Deficiency Disorder (CDD), Tuberous Sclerosis Complex (TSC), and PCDH19 pediatric epilepsy. The company plans to use March 2022 funds for ZTALMY® (ganaxolone) oral suspension for the treatment of seizures associated with CDKL5 deficiency (CDD) in patients 2 years of age and older.
Who invested in Marinus Pharmaceuticals
5 investors across 4 rounds
See all investors in Marinus Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Marinus Pharmaceuticals
Who invested in Marinus Pharmaceuticals?
Marinus Pharmaceuticals has 5 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Marinus Pharmaceuticals raised?
Marinus Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Marinus Pharmaceuticals last raise money?
Marinus Pharmaceuticals's most recent round on record is a Series C, in Jan 2013.
What does Marinus Pharmaceuticals do?
Based in Pennsylvania, US, and founded in 2003, Marinus Pharmaceuticals, Inc.
Where is Marinus Pharmaceuticals headquartered?
Marinus Pharmaceuticals is headquartered in Radnor, US.
Which VCs invest in companies like Marinus Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Marinus Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Marinus Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.